Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Tyrosine-protein kinase ABL1 | ||
Ligand | BDBM50318870 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_633633 (CHEMBL1117891) | ||
IC50 | 68±n/a nM | ||
Citation | Allen, JG; Fotsch, C; Babij, P Emerging targets in osteoporosis disease modification. J Med Chem53:4332-53 (2010) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Tyrosine-protein kinase ABL1 | |||
Name: | Tyrosine-protein kinase ABL1 | ||
Synonyms: | ABL | ABL1 | ABL1_HUMAN | Abelson murine leukemia viral oncogene homolog 1 | JTK7 | Proto-oncogene c-Abl | Proto-oncogene tyrosine-protein kinase ABL1 | Tyrosine-protein kinase (ABL) | Tyrosine-protein kinase ABL | Tyrosine-protein kinase ABL1 (ABL) | V-abl Abelson murine leukemia viral oncogene homolog 1 | c-ABL | p150 | tyrosine-protein kinase ABL1 isoform a | ||
Type: | Enzyme | ||
Mol. Mass.: | 122897.30 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P00519 | ||
Residue: | 1130 | ||
Sequence: |
| ||
BDBM50318870 | |||
n/a | |||
Name | BDBM50318870 | ||
Synonyms: | ((4-(2-(cis-4-aminocyclohexyl)-9-ethyl-9H-purin-6-ylamino)phenyl)(hydroxy)phosphoryl)methylphosphonic acid | 2,6,9-Trisubstituted Purine, 8 | 2,6,9-Trisubstituted Purine, AP23451 | CHEMBL1084268 | ||
Type | Small organic molecule | ||
Emp. Form. | C20H28N6O5P2 | ||
Mol. Mass. | 494.421 | ||
SMILES | CCn1cnc2c(Nc3ccc(cc3)P(O)(=O)CP(O)(O)=O)nc(nc12)[C@H]1CC[C@H](N)CC1 |r,wU:26.28,wD:29.32,(30.94,-9.82,;29.4,-9.81,;28.64,-8.49,;29.54,-7.24,;28.63,-6,;27.17,-6.48,;25.83,-5.71,;25.82,-4.17,;27.15,-3.4,;28.49,-4.17,;29.82,-3.4,;29.82,-1.86,;28.47,-1.09,;27.14,-1.87,;31.15,-1.08,;31.03,-2.56,;31.14,.46,;32.48,-1.85,;33.81,-1.07,;35.15,-1.84,;33.8,-2.61,;33.81,.47,;24.5,-6.48,;24.5,-8.02,;25.83,-8.79,;27.17,-8.02,;23.17,-8.79,;23.17,-10.33,;21.82,-11.1,;20.49,-10.33,;19.16,-11.1,;20.49,-8.79,;21.82,-8.01,)| | ||
Structure |